Armour Therapeutics has been funded by and is collaborating with top institutions and investigators for the purpose of conducting preclinical research. Our partnering strategy is to leverage the strength of the broad potential of our development compounds to establish strategic alliances that provide access to complementary technology and expertise. These alliances provide significant support for our internal development programs and open the door to additional product opportunities.

Armour Therapeutics is developing a pipeline of candidates for anti-hormone therapy for cancer. The Company is actively seeking collaborations to enhance this mission and is interested in acquiring exclusive intellectual property rights for therapeutics and diagnostics towards the treatment of prostate cancer.

For business development contact:


© 2016 Armour Therapeutics Inc. All Rights Reserved.